Gastroenterology Flashcards

1
Q

Treatment of Barrett’s with a reduction in adenocarcinoma

A

High dose PPI and aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Barrett’s surveillance

A

No dysplasia - surveillance
Low grade at 2 endos 6 months apart- RFA
High grade dysplasia - oesophagectomy vs low endo resection followed by RFA
Post RFA - 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Portal HTN pressure

A

> 5mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Primary prophylaxis if nil bleed

A

Non selective b blocker or ligation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prevention of hepatorenal syndrome in SBP

A

IV albumen at diagnosis and day 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

High ALP and GGT and antimitochondrial antibodies

A

PBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PBC treatment

A

Ursodeoxycholic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Liver transplant referral

A

Kings college criteria (not paracetamol)

PT >100 OR 3 of

Age over 40

Jaundice for 7 days

PT over 50

Bili over 180

Non A or Non B hepatitis, Wilson’s or drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type 1 AIH

A

Anti Smooth muscle antibodies and ANA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type 2 AIH

A

Anti LKM1

Target antigen: Cyp450 2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Haemachromatosis gene mutation

A

HFE gene mutation (C282Y or H63D)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Test for Pancreatic insufficiency with chronic pancreatitis

A

Faecal elastase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

FAP gene

A

APC gene chromosome 5

Tumour suppressor gene

Autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MYH associated polyposis

A

MutY gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HNPCC gene mutations

A

MSH2 (60%) and MLH1 (30%)

Mismatch repair genes causing micro satellite instability

Right sided tumour

> 10 adenomas

3 cases, 2 generations, 1 age <50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5-AZA SE

A
Hepatotoxicity
Myelosuppressions
Allergy/pancreatitis 
NHL 
Non melanomatous skin cancer 

No effect in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risk of progression from high grade dysplasia to adenocarcinoma

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The benefit of IV PPI pre endoscopy

A

Reduces endoscopy therapy does not reduce mortality, rebleed or death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment of acute bleeding UGIB

A

Adrenaline + diathermy/clip has mortality/rebleed benefit
Post endoscopy PPI IV for 72 hours (oral similarly efficacious)
Restart aspirin at 3 days
Restart warfarin/DOAC 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

High gradient ascites

A

Serum albumin: ascites alumen >11g/L

Portal HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Low gradient ascites

A

<11g/L ‘Leaky capillaries (infection) or cancer

22
Q

Treatment of SBP

A

WCC >250
Cefotaxime 2g TDS
Cease beta blockers (mortality risk)
Bactrim prophylaxis

23
Q

Histology of alcoholic liver disease

A

Mallory-Denk hyalines surrounded by neutrophils (termed Mallory-Denk bodies)
macrovesicular steatosis

24
Q

Histology of NASH

A

fat droplets in the hepatocytes in association with ballooning degeneration and lobular inflammation.

25
DNA stool test for CRC
``` KRAS mutation NDRG4 BMP3 methylation Beta actin Haemoglobin immunoassay ```
26
When to refer cirrhosis for transplant
Evidence of hepatic dysfunction (child’s Pugh 7 or meld >10) or first complication (ascites varicella bleed or hepatic encephalopathy)
27
Child Pugh score
``` Albumin Bilirubin Coagulation (pt inr) Drain the ascites Encephalopathy ```
28
Ferroportin
Stimulates iron release from entericyte into blood stream at basolateral surface
29
Hepcidin
Inhibits iron release from enterocyte ast basolateral membrane
30
Genetic variant of crowns disease which could lead to early initial surgery due to structures
NOD2/CARD15
31
Positive pANCA negative ASCA
UC
32
Negative pANCA pos ASCA
Crohns
33
Drug for Crohn's with anti-IL12/23 action
Ustekinumab
34
Hormones that stimulate appetite
Ghrelin Neuropeptide Agouty related peptide
35
IBD drugs to avoid in pregnancy
MTX contraindicated | Infliximab (anti-TNF) should be avoided in third trimester
36
Indication for elective total colectomy in UC patients
Risk of cancer Unable to wean steroids Steriod side effects
37
UC/Crohn's surveillance
Colonoscopy 8 years from disgnosis every 1-3 years
38
Diarrhoea associated with resection of terminal ileum
Bile malabsorption related
39
Serology coeliac
1) Tissue transglutaminase Ab (IgA-tTG)(most accurate) or Endomysial Ab (IgA-EMA). 2) Anti-gliadin Ab (less sensitive/specific) HLA-DQ2 DQ8 - rule out test
40
When to treat with Abx in acute pancreatitis
If necrosis is present
41
Corckskrew oesophagus
Oesophageal spasm | Most commonly in seting of uncontrolled GERD
42
Most common cause of viral gastro
norovirus
43
therpaeutic effect of lactulose
lowers faeces pH
44
Interferon treatment of HCV
Interferon alfa-2b (5 million U) of subcutaneously daily for 4 weeks and then three times per week for 20 weeks
45
MELD score
Creatinine Bilirubin INR
46
autoimmune pancreatitis serological test?
IgG4
47
Diagnosis of wilsons disease
Low serum copper and ceruloplasmin levels High 24 urine copper Rx: trientine and zinc
48
HCC finding on quad phase imaging
Enhance on arterial imaging rapidly | Wash out in arterial phase
49
Serum albumin gradient > 1.1 and ascites protein <2.5
Cirrhosis Budd Chiari Liver mets
50
Barrett's oesophagus histology
Intestinal metaplasia characterized with goblet cells.
51
Most specific autoimmune hepatitis
Anti-SLA/LP (Soluble Liver Antigen/Liver–Pancreas Antigen)
52
Medication for post-ERCP pancreatitis
NSAIDS i.e. indomethacin pre ERCP